The Rosen Law Firm has filed a securities class action lawsuit on behalf of investors who bought Webull Corporation shares between April 2025 and October 2026. The suit alleges Webull misled investors by hiding the extent of its operations and data infrastructure ties to mainland China, falsely claiming its business and customer data were primarily U.S.-based and insulated from Chinese access. Investors who purchased Webull securities during this period may be entitled to compensation. Those interested in joining the class action must act by December 7, 2026, to seek lead plaintiff status or participate in the case.
The Rosen Law Firm's securities class action involving Webull Corporation is presented here with a snapshot of the Technology sector on Pluang as of Oct 10, 2026 00:11 WIB. Among 150 priced Technology-sector US stocks, 94 rose and 54 fell. Oracle Corporation (ORCL) gained 4.62% to USD 141.30 with a typical hold time of 72 days and a Pluang order activity favoring buys at 57%, contrasting with Expensify Inc (EXFY) which rose 4.78% to USD 2.41 but saw 100% sell orders and a shorter hold time of 41 days. Meanwhile, AXT Inc (AXTI) declined 4.44% to USD 68.48 with a typical hold time of 17 days and 77% buy orders.
A class action lawsuit has been filed against The Ensign Group alleging systematic neglect and abuse of elderly residents in its care facilities, including inadequate food, medical attention, and hygiene. The lawsuit claims the company defrauded Medi...
Barclays downgraded Joby Aviation from Equal-Weight to Underweight due to concerns about its future market share in the electric aircraft sector. Following the downgrade, Joby's stock fell sharply by 9%, trading near its 52-week low with a market cap...
Several analysts have reduced their price targets for CRH plc, a leading building materials company, with RBC Capital lowering its target from $165 to $135 while keeping an Outperform rating. Despite the cuts, the new targets still imply significant ...
Zscaler's shares rose 6% after reaffirming its full-year revenue forecast of $3.91-$3.94 billion and announcing a collaboration with IBM and Red Hat to protect private applications during vulnerability windows. This news boosted the entire cybersecur...
Novavax shares surged 16%, leading a biotech sector rally alongside Moderna's 11% gain and Merck's 3% rise. The spike occurred without any new company-specific announcements, driven by a broad sector-wide bid in vaccine and biotech stocks. Novavax's ...
